Cleared Traditional

SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option (K250650) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250650 · Arineta , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
42d
Days
Class 2
Risk

K250650 is an FDA 510(k) clearance for the SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Arineta , Ltd. (Caesarea, IL). The FDA issued a Cleared decision on April 15, 2025 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Arineta , Ltd. devices

Submission Details

510(k) Number K250650 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2025
Decision Date April 15, 2025
Days to Decision 42 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 107d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 421
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K250650.
SCENARIA View Phase 5.0
K250370 · Fujifilm Corporation · May 2025
uCT ATLAS Astound with uWS-CT-Dual Energy Analysis
K243617 · Shanghai United Imaging Healthcare Co., Ltd. · May 2025
Spectral CT
K244008 · Philips Medical Systems Technologies , Ltd. · May 2025
Vitrea CT VScore
K243240 · Canon Medical Informatics, Inc. · Apr 2025
BodyTom 64
K242811 · Neurologica Corporation, A Subsidiary of Samsung · Mar 2025
Brainomix 360 e-Lung
K242411 · Brainomix Limited · Feb 2025